Extravascular use of drug-eluting beads: A promising approach in compartment-based tumor therapy

doi:10.3748/wjg.v19.i43.7586

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 43

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8092)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

456

HTML

4660

Figures (1-3)

259

Sum=5375

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1431

Download

1286

Sum=2717

Nov 21, 2013 (publication date) through Jan 21, 2025

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Nov 21, 2013; 19(43): 7586-7593
Published online Nov 21, 2013. doi: 10.3748/wjg.v19.i43.7586

Full Size Figure Download Figure

Figure 2 Doxorubicin-eluting beads. A: HE-stained, magnification × 50: A layer of fibrin (between arrows) immobilizing the doxorubicin-loaded DC beads (DOXDEB™) on the livers surface; B: HE-stained, magnification × 100: DOXDEB™ in layer of fibrin and surrounded by lymphocytes immobilizing it on mesenteric connective tissue.

Citation: Binder S, Lewis AL, Löhr JM, Keese M. Extravascular use of drug-eluting beads: A promising approach in compartment-based tumor therapy. World J Gastroenterol 2013; 19(43): 7586-7593
URL: https://www.wjgnet.com/1007-9327/full/v19/i43/7586.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i43.7586